Key Highlights

● MCK shares ended 9 October 2026 at $937.66.

● Market data consensus target is $983.29, implying about 4.87% upside.

● The analyst rating consensus is Buy.

● Royal Bank of Canada reiterated its rating on 14 September.

On Friday 9 October 2026, McKesson (NYSE:MCK), a member of the S&P 500, closed at $937.66. The consensus target sits close to the share price. Recent broker revisions have mostly been upward.

What Is the Latest Analyst Price Target?

Market data reports a consensus 12-month price target of $983.29 from 19 analysts with ratings in the past year, ranging from $845 to $1,080. Against the $937.66 close, the consensus target suggests upside of about 4.87%. Market data's split is 15 Buy, four Hold and no Sell, a Moderate Buy consensus.

What Are Wall Street Analysts Saying?

The second data set, using third-party data, shows a mean of $979.36, a median of $1,000, a high of $1,065 and a low of $845 from 17 analysts, as of 6 October 2026.

Named actions on market data include Leerink Partners raising its target from $1,030 to $1,070 with an Outperform rating on 7 October 2026, and Morgan Stanley setting $977 on 6 October. Royal Bank of Canada reiterated Sector Perform with $845 on 14 September, and Argus raised its target from $850 to $970 (Buy) on 3 September. Barclays raised its target from $925 to $1,000 (Overweight) on 19 August, and Wells Fargo raised its from $812 to $933 (Equal Weight) on 11 August. In early August, UBS ($1,080), Baird ($1,015), TD Cowen ($1,006) and Bank of America ($1,050) were among others lifting targets, while Evercore cut from $1,000 to $950 and Mizuho raised to $905.

What Could Help the Stock Reach the Price Target?

Recent broker activity has been mostly upward, which supports the consensus. Headlines also mention an extended distribution agreement with CVS Health (NYSE:CVS) through June 2032 and a deal to acquire Option Care Health (NASDAQ:OPCH). If integration and distribution volumes go well, analysts may keep raising forecasts.

What Could Prevent the Stock Reaching the Target?

With the shares less than 5% below the average target, the implied upside is modest compared with many large-cap stocks. Several targets sit at or below the current price, including Royal Bank of Canada's $845 and Wells Fargo's $933 and Mizuho's $905. A large acquisition can bring financing, integration and regulatory risks. Healthcare distribution is also exposed to drug pricing policy, customer concentration and contract renewals, any of which could weigh on sentiment.

What Should Investors Watch Next?

Investors may wish to watch the next quarterly results and any further guidance changes, as well as progress on the Option Care Health transaction. It is also worth tracking whether the targets of the more cautious brokers move towards the current share price.

How Analysts See McKesson After the Latest Close

McKesson closed at $937.66 on 9 October 2026, against a market data consensus target of $983.29. Royal Bank of Canada reiterated Sector Perform with $845 on 14 September, and Argus raised its target from $850 to $970 (Buy) on 3 September.